Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

James Suen

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arteriovenous Malformations
9
2018
76
1.540
Why?
Head and Neck Neoplasms
14
2012
288
1.290
Why?
Carcinoma, Squamous Cell
12
2011
326
0.880
Why?
Neck
7
2018
99
0.710
Why?
Vascular Malformations
3
2010
102
0.660
Why?
Head
5
2018
71
0.630
Why?
Patients
1
2018
48
0.580
Why?
Terminal Care
1
2018
46
0.580
Why?
Hemangioma
3
2018
83
0.550
Why?
Attitude to Health
1
2018
193
0.540
Why?
Laryngectomy
3
2013
27
0.540
Why?
Flow Cytometry
7
2024
474
0.540
Why?
Laryngeal Neoplasms
2
2007
43
0.510
Why?
Carcinoma, Merkel Cell
4
2016
40
0.470
Why?
Quality of Life
3
2012
852
0.470
Why?
Laser Therapy
3
2011
83
0.460
Why?
Laryngeal Diseases
1
2013
12
0.420
Why?
Herpes Simplex
1
2013
21
0.410
Why?
Nuclear Proteins
6
2015
238
0.410
Why?
Parotid Diseases
1
2012
3
0.410
Why?
Neuromuscular Agents
1
2012
7
0.410
Why?
Botulinum Toxins, Type A
1
2012
13
0.410
Why?
Leukoplakia, Oral
1
2011
6
0.390
Why?
Aminolevulinic Acid
1
2011
8
0.390
Why?
Lasers, Dye
1
2011
10
0.380
Why?
Eating
1
2012
158
0.380
Why?
Photosensitizing Agents
1
2011
19
0.380
Why?
Photochemotherapy
1
2011
33
0.370
Why?
Survivors
1
2012
127
0.370
Why?
Female
30
2024
27086
0.360
Why?
Humans
49
2024
50516
0.360
Why?
Middle Aged
21
2024
12613
0.350
Why?
Male
30
2024
25913
0.350
Why?
Photoacoustic Techniques
2
2024
71
0.340
Why?
Cheek
1
2010
9
0.340
Why?
Lip
1
2010
10
0.340
Why?
Neoplastic Cells, Circulating
4
2019
74
0.340
Why?
Facial Neoplasms
1
2010
22
0.330
Why?
Pain
1
2012
389
0.330
Why?
Adult
21
2024
13584
0.330
Why?
Receptors, Progesterone
1
2009
64
0.320
Why?
Aged
16
2018
9743
0.320
Why?
Postoperative Complications
3
2012
1033
0.310
Why?
Lymphatic Vessels
1
2009
53
0.310
Why?
Skin Neoplasms
4
2016
491
0.310
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
1000
0.300
Why?
Neoplasms
1
2018
1255
0.300
Why?
Surgical Flaps
1
2009
114
0.290
Why?
Recurrent Laryngeal Nerve
1
2007
12
0.290
Why?
Laryngeal Nerves
1
2007
15
0.290
Why?
Melanoma
2
2022
280
0.280
Why?
Factor VII
1
2007
3
0.280
Why?
Erythrocytes
2
2024
83
0.280
Why?
Intracranial Arteriovenous Malformations
1
2007
30
0.270
Why?
Dilatation
2
2017
26
0.270
Why?
Malaria
2
2024
37
0.250
Why?
Adolescent
11
2024
6446
0.240
Why?
Gene Silencing
4
2009
115
0.240
Why?
Disease Models, Animal
3
2016
1436
0.230
Why?
Cell Proliferation
4
2016
985
0.210
Why?
Melanoma, Experimental
2
2016
40
0.210
Why?
Retrospective Studies
10
2015
6264
0.210
Why?
Immunohistochemistry
8
2014
957
0.200
Why?
Treatment Outcome
7
2018
5285
0.200
Why?
Xerostomia
1
2002
2
0.200
Why?
Muscarinic Agonists
1
2002
11
0.200
Why?
Promoter Regions, Genetic
7
2015
465
0.200
Why?
Sjogren's Syndrome
1
2002
9
0.200
Why?
Endoscopy
2
2015
119
0.200
Why?
Thiophenes
1
2002
36
0.200
Why?
Plasmodium yoelii
1
2022
14
0.200
Why?
Nitric Oxide Synthase Type III
2
2013
78
0.190
Why?
Quinuclidines
1
2002
40
0.190
Why?
Transcription Factors
2
2015
565
0.180
Why?
Veins
3
2010
73
0.180
Why?
Embolization, Therapeutic
3
2011
88
0.180
Why?
Azepines
3
2016
19
0.180
Why?
Triazoles
3
2016
113
0.170
Why?
Child
10
2012
6910
0.170
Why?
Neoplasm Invasiveness
3
2010
269
0.160
Why?
Child, Preschool
8
2012
3943
0.160
Why?
Mast Cells
1
2018
54
0.150
Why?
Mice
10
2022
5687
0.150
Why?
Ki-67 Antigen
3
2013
56
0.150
Why?
Combined Modality Therapy
4
2018
641
0.140
Why?
Cricoid Cartilage
1
2017
11
0.140
Why?
Estradiol
1
2018
221
0.140
Why?
Trachea
1
2017
52
0.140
Why?
Mice, Nude
5
2016
248
0.140
Why?
Biopsy
3
2015
588
0.130
Why?
Follow-Up Studies
3
2011
2242
0.130
Why?
Infant
7
2018
3629
0.130
Why?
Lasers, Semiconductor
2
2022
10
0.130
Why?
Embolism
1
2016
20
0.130
Why?
Neoplasm Staging
2
2010
746
0.130
Why?
Benzoxazoles
1
2016
11
0.130
Why?
Matrix Metalloproteinase 2
1
2016
59
0.130
Why?
Qualitative Research
1
2018
348
0.130
Why?
Matrix Metalloproteinase 9
1
2016
88
0.130
Why?
Tracheotomy
1
2015
14
0.130
Why?
TOR Serine-Threonine Kinases
1
2016
78
0.120
Why?
Tracheal Stenosis
1
2015
12
0.120
Why?
Laryngostenosis
1
2015
11
0.120
Why?
Aged, 80 and over
6
2015
3227
0.120
Why?
Proto-Oncogene Proteins c-myb
1
2015
8
0.120
Why?
Larynx
2
2017
30
0.120
Why?
Pyrimidines
1
2016
191
0.120
Why?
Proto-Oncogene Proteins c-myc
1
2014
50
0.120
Why?
Disease Progression
3
2014
829
0.110
Why?
Fluorouracil
2
2004
58
0.110
Why?
Gene Expression Regulation, Neoplastic
3
2015
833
0.110
Why?
Carcinoma
2
2012
137
0.110
Why?
DNA Methylation
5
2009
550
0.110
Why?
Plasmodium falciparum
2
2024
19
0.110
Why?
Breast Neoplasms
2
2015
1200
0.110
Why?
Apoptosis
2
2016
1097
0.110
Why?
Animals
10
2022
13124
0.110
Why?
Mastication
1
2012
5
0.100
Why?
Trismus
1
2012
2
0.100
Why?
DNA, Neoplasm
2
2011
143
0.100
Why?
Cisplatin
2
2004
286
0.100
Why?
Adaptor Proteins, Signal Transducing
3
2009
198
0.100
Why?
Radiotherapy, Adjuvant
1
2012
64
0.100
Why?
Recurrence
2
2011
659
0.100
Why?
Receptors, Cell Surface
1
2013
116
0.100
Why?
Lymphangioma, Cystic
1
2011
10
0.100
Why?
Chemoradiotherapy
1
2012
42
0.100
Why?
Endothelium, Lymphatic
1
2011
12
0.100
Why?
Cross-Sectional Studies
3
2024
1608
0.100
Why?
Syndrome
1
2012
240
0.100
Why?
Antigens, CD
1
2013
222
0.100
Why?
Administration, Topical
1
2011
57
0.100
Why?
Epigenesis, Genetic
1
2015
372
0.100
Why?
Propranolol
1
2012
79
0.090
Why?
Lymphatic Abnormalities
1
2011
22
0.090
Why?
Immunoenzyme Techniques
4
2016
137
0.090
Why?
Enteral Nutrition
1
2012
150
0.090
Why?
Microtubule-Associated Proteins
1
2011
66
0.090
Why?
Deglutition Disorders
1
2012
77
0.090
Why?
Homeodomain Proteins
1
2011
79
0.090
Why?
Brain Neoplasms
1
2014
291
0.090
Why?
Diagnosis, Differential
2
2011
1033
0.090
Why?
Tumor Suppressor Proteins
1
2011
128
0.090
Why?
Risk Assessment
1
2015
1269
0.090
Why?
Weight Gain
1
2012
237
0.090
Why?
Epigenomics
1
2011
68
0.090
Why?
Xenograft Model Antitumor Assays
3
2016
212
0.090
Why?
Lip Neoplasms
1
2010
3
0.090
Why?
Neoplasm Proteins
2
2003
320
0.090
Why?
Diagnostic Imaging
1
2011
181
0.080
Why?
Neoplastic Stem Cells
1
2011
98
0.080
Why?
Neoplasm Recurrence, Local
2
2019
629
0.080
Why?
Survival Rate
3
2011
909
0.080
Why?
Hospitals, Teaching
1
2010
54
0.080
Why?
Lasers, Solid-State
1
2010
32
0.080
Why?
Neoadjuvant Therapy
1
2011
120
0.080
Why?
Microsatellite Instability
1
2009
19
0.080
Why?
Medical Records
1
2010
85
0.080
Why?
Mouth
1
2010
32
0.080
Why?
Young Adult
3
2024
4107
0.080
Why?
Melanins
1
2009
27
0.080
Why?
Vascular Surgical Procedures
1
2011
166
0.080
Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
Why?
Carcinoma, Medullary
1
2009
12
0.080
Why?
Pilot Projects
1
2011
699
0.080
Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.080
Why?
Immunotherapy
1
2011
235
0.080
Why?
Receptors, Estrogen
1
2009
132
0.080
Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
22
0.080
Why?
Muscle, Smooth, Vascular
1
2009
131
0.080
Why?
Port-Wine Stain
1
2008
14
0.080
Why?
Blotting, Western
3
2016
578
0.070
Why?
Dose-Response Relationship, Drug
1
2011
1372
0.070
Why?
Vascular Endothelial Growth Factor A
1
2008
182
0.070
Why?
Early Detection of Cancer
2
2022
163
0.070
Why?
Cytokines
1
2011
606
0.070
Why?
Thyroid Neoplasms
1
2009
112
0.070
Why?
Tumor Cells, Cultured
3
2016
457
0.070
Why?
Factor VIIa
1
2007
9
0.070
Why?
Jaw Diseases
1
2007
6
0.070
Why?
Practice Guidelines as Topic
1
2010
468
0.070
Why?
Infant, Newborn
2
2011
2749
0.070
Why?
Practice Management, Medical
1
2006
10
0.070
Why?
Osteonecrosis
1
2007
34
0.070
Why?
Postoperative Hemorrhage
1
2007
52
0.070
Why?
Tongue
1
2007
40
0.070
Why?
Bone Density Conservation Agents
1
2007
74
0.070
Why?
Cell Line, Tumor
3
2015
1398
0.060
Why?
Diphosphonates
1
2007
90
0.060
Why?
Otolaryngology
1
2006
61
0.060
Why?
Skin
1
2008
389
0.060
Why?
Recombinant Proteins
1
2007
476
0.060
Why?
Prospective Studies
1
2011
2378
0.060
Why?
Mice, Inbred NOD
2
2016
91
0.060
Why?
Cameroon
1
2024
4
0.060
Why?
Mice, SCID
2
2016
178
0.060
Why?
Hemeproteins
1
2024
8
0.060
Why?
Parasitemia
1
2024
8
0.060
Why?
Malaria, Falciparum
1
2024
14
0.060
Why?
Neoplasm Metastasis
2
2015
232
0.060
Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2004
9
0.060
Why?
DNA Repair Enzymes
1
2004
43
0.060
Why?
Ataxia Telangiectasia
1
2004
6
0.060
Why?
Statistics, Nonparametric
1
2004
193
0.060
Why?
ROC Curve
1
2024
226
0.060
Why?
Polymerase Chain Reaction
4
2009
449
0.060
Why?
Genes, p16
1
2003
8
0.050
Why?
Lymph Node Excision
1
2004
131
0.050
Why?
Radiotherapy
1
2004
125
0.050
Why?
Proteoglycans
1
2003
83
0.050
Why?
Magnetic Resonance Angiography
2
2018
71
0.050
Why?
Antigens, Nuclear
2
2013
23
0.050
Why?
Magnetic Resonance Imaging
2
2007
1556
0.050
Why?
Transplantation, Heterologous
2
2013
75
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
572
0.050
Why?
Sensitivity and Specificity
1
2024
861
0.050
Why?
Longitudinal Studies
1
2024
735
0.050
Why?
Membrane Glycoproteins
1
2003
245
0.050
Why?
Double-Blind Method
1
2002
708
0.040
Why?
Survival Analysis
3
2009
661
0.040
Why?
Tryptases
1
2018
4
0.040
Why?
Estrogen Receptor beta
1
2018
55
0.040
Why?
Arkansas
1
2004
1984
0.040
Why?
Estrogen Receptor alpha
1
2018
88
0.040
Why?
Protein Transport
1
2018
181
0.040
Why?
Ultrasonography, Doppler
1
2018
41
0.040
Why?
Biopsy, Fine-Needle
2
2009
108
0.040
Why?
Cadaver
1
2017
96
0.040
Why?
Pressure
1
2017
104
0.040
Why?
Serum
1
2016
32
0.030
Why?
Risk Factors
3
2015
3723
0.030
Why?
Molecular Imaging
1
2016
54
0.030
Why?
Drug Synergism
1
2016
151
0.030
Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
17
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2016
181
0.030
Why?
Enhancer Elements, Genetic
1
2015
58
0.030
Why?
Acetylation
1
2015
94
0.030
Why?
Keratin-20
1
2014
7
0.030
Why?
Mammography
1
2015
101
0.030
Why?
G1 Phase Cell Cycle Checkpoints
1
2014
16
0.030
Why?
Drug Therapy, Combination
1
2016
384
0.030
Why?
Prognosis
3
2004
1977
0.030
Why?
Chromatin
1
2015
137
0.030
Why?
Cell Cycle Proteins
1
2015
161
0.030
Why?
HEK293 Cells
1
2014
213
0.030
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2013
30
0.030
Why?
Gene Expression Regulation
1
2018
955
0.030
Why?
Comorbidity
1
2015
623
0.030
Why?
Protein Binding
1
2015
654
0.030
Why?
Down-Regulation
1
2014
340
0.030
Why?
Actins
1
2013
114
0.030
Why?
RNA, Messenger
1
2016
1089
0.030
Why?
Base Sequence
2
2004
639
0.020
Why?
Lymphocele
1
2011
7
0.020
Why?
Tissue Survival
1
2011
10
0.020
Why?
Cell Line
1
2014
988
0.020
Why?
Predictive Value of Tests
1
2014
930
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
45
0.020
Why?
Tissue Culture Techniques
1
2011
37
0.020
Why?
Neoplasms, Squamous Cell
1
2011
7
0.020
Why?
Gluconates
1
2011
1
0.020
Why?
Gene Expression Profiling
1
2016
1025
0.020
Why?
Graft Survival
1
2011
159
0.020
Why?
Indomethacin
1
2011
38
0.020
Why?
Injections, Subcutaneous
1
2011
52
0.020
Why?
Interleukin-2
1
2011
71
0.020
Why?
Carrier Proteins
2
2003
298
0.020
Why?
Time Factors
2
2007
2935
0.020
Why?
Interleukin-1beta
1
2011
72
0.020
Why?
Cyclophosphamide
1
2011
168
0.020
Why?
Interferon-gamma
1
2011
177
0.020
Why?
Drug Administration Schedule
1
2011
370
0.020
Why?
Disease-Free Survival
1
2011
444
0.020
Why?
Glottis
1
2010
34
0.020
Why?
Endothelial Cells
1
2011
258
0.020
Why?
Sclerotherapy
1
2010
46
0.020
Why?
Calcitonin
1
2009
30
0.020
Why?
Tumor Necrosis Factor-alpha
1
2011
393
0.020
Why?
Thyroidectomy
1
2009
60
0.020
Why?
Paraffin Embedding
1
2008
51
0.020
Why?
Mice, Transgenic
1
2009
540
0.020
Why?
Signal Transduction
1
2014
1624
0.020
Why?
Curettage
1
2007
12
0.020
Why?
Dental Care
1
2007
11
0.020
Why?
Mouth Floor
1
2007
5
0.020
Why?
Polyvinyl Alcohol
1
2007
9
0.020
Why?
Hyperbaric Oxygenation
1
2007
15
0.020
Why?
Current Procedural Terminology
1
2006
7
0.020
Why?
Collateral Circulation
1
2007
39
0.020
Why?
Pharyngeal Diseases
1
2007
12
0.020
Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
Why?
Cutaneous Fistula
1
2007
14
0.020
Why?
Neck Dissection
1
2007
30
0.020
Why?
Office Visits
1
2006
44
0.020
Why?
Angiography
1
2007
128
0.020
Why?
Fistula
1
2007
26
0.020
Why?
Salvage Therapy
1
2007
137
0.020
Why?
Adrenal Cortex Hormones
1
2007
99
0.020
Why?
Genetic Predisposition to Disease
1
2009
510
0.020
Why?
Imidazoles
1
2007
127
0.020
Why?
Preoperative Care
1
2007
169
0.020
Why?
Ultrasonography
1
2006
435
0.010
Why?
United States
1
2015
4955
0.010
Why?
Guanine
1
2004
40
0.010
Why?
DNA Adducts
1
2004
79
0.010
Why?
Methylation
1
2004
118
0.010
Why?
Syndecans
1
2003
37
0.010
Why?
Syndecan-1
1
2003
75
0.010
Why?
Base Pair Mismatch
1
2003
22
0.010
Why?
Cell Count
1
2003
150
0.010
Why?
Antineoplastic Agents
1
2011
1172
0.010
Why?
DNA Repair
1
2003
188
0.010
Why?
Alcohol Drinking
1
2003
227
0.010
Why?
Molecular Sequence Data
1
2003
778
0.010
Why?
Anti-Bacterial Agents
1
2007
745
0.010
Why?
Smoking
1
2003
507
0.010
Why?
Multiple Myeloma
1
2007
2998
0.010
Why?
Suen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description